The stability factor: Importance in formulation development

Current Pharmaceutical Biotechnology

Volumn 3, Issue 4, 2002, Pages 361-371

  Krishnamurthy, Rajesh ^a   Manning, Mark C ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; CITRIC ACID; EDETIC ACID; FLT3 LIGAND; GAMMA INTERFERON; GUANIDINE; HEPARIN; INTERFERON BETA SERINE; N ACETYLTRYPTOPHAN; OCTANOIC ACID; POLYSORBATE 80; RECOMBINANT INTERLEUKIN 2; RECOMBINANT KERATINOCYTE GROWTH FACTOR; RECOMBINANT PROTEIN; RIBONUCLEASE A; SUCROSE; SURFACTANT; THYMIDYLATE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA; TRIPOLYPHOSPHATE; UREA; PROTEIN;

ADSORPTION; AQUEOUS SOLUTION; CHEMICAL MODIFICATION; CIRCULAR DICHROISM; CONTROLLED STUDY; DEAMINATION; DECOMPOSITION; DENATURATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DESIGN; DRUG FORMULATION; DRUG SCREENING; FLUORESCENCE SPECTROSCOPY; HYDROGEN BOND; HYDROPHOBICITY; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; OXIDATION; PHYSICAL CHEMISTRY; PRECIPITATION; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW; SOLID STATE; THERMODYNAMICS; ANIMAL; CHEMISTRY; DRUG STABILITY; HUMAN; METHODOLOGY; SYNTHESIS;

BOVINAE;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG STABILITY; HUMANS; PROTEINS; THERMODYNAMICS;

EID: 0036890693     PISSN: 13892010     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389201023378229     Document Type: Review

References (123)

1. Carpenter, J.F.; Pikal, M.J.; Chang, B.S. and Randolph, T.W. (1997) Pharm. Res., 14, 969-975.
2. Manning, M.C.; Patel, K. and Borchardt, R.T. (1989) Pharm. Res., 6, 903-918.
3. Cleland, J.L.; Powell, M.F. and Shire, S.J. (1993) Crit. Rev. Ther. Drug Carrier Syst., 10, 307-377.
4. Volkin, D.B.; Mach, H. and Middaugh, C.R. (1997) Mol. Biotechnol., 8, 105-122.
5. Arakawa, T.; Prestrelski, S.J.; Kenney, W.C. and Carpenter, J.F. (2001) Adv. Drug Deliv. Rev., 46, 307-326.
6. Timasheff, S.N. (1998) Adv. Protein Chem., 51, 355-432.
7. Wyman, J. (1982) Adv. Exp. Med. Biol., 148, 23-30.
8. Lee, J.C. and Timasheff, S.N. (1977) Biochemistry, 16, 1754-1764.
9. Kita, Y.; Arakawa, T.; Lin, T-Y. and Timasheff, S.N. (1994) Biochemistry, 33, 15178-15189.
10. Fersht, A. (1985) Enzyme Structure and Mechanism, 2nd ed., Freeman, W.H. and Company, New York.
11. Dill, K.A. (1990) Biochemistry, 29, 7133-7155.
12. Stellwagen, E.; Park, S.H.; Shalongo, W. and Jain, A. (1992) Biopolymers, 32, 1193-1200.
13. Olson, C.A.; Spek, E.J.; Shi, Z.; Vologodskii, A. and Kallenbach, N.R. (2001) Proteins, 44, 123-132.
14. Pace, C.N.; Laurents, D.V. and Erickson, R.E. (1992) Biochemistry, 31, 2728-2734.
15. Yang, A-H. and Honig, B. (1993) J. Mol. Biol., 223, 459-474.
16. Barlow, D.J. and Thornton, J.M. (1983) J. Mol. Biol., 168, 867- 875.
17. Anderson, D.E.; Becktel, W.J. and Dahlquist, F.W. (1990) Biochemistry, 29, 2403-2408.
18. Pace, C.N. and Grimsley, G.R. (1988) Biochemistry, 27, 3242-3246.
19. Zipp, A. and Kauzmann, W. (1973) Biochemistry, 12, 4217-4228.
20. Tanford, C. (1968) Adv. Protein Chem., 23, 121-282.
21. Warshel, A. and Levitt, M. (1976) J. Mol. Biol., 103, 227-249.
22. Bolen, D.W and Baskakov, I.V. (2001) J. Mol. Biol., 310, 955-963.
23. Pace, C.N.; Shirley, B.A.; McNutt, M. and Gajiwala K. (1996) FASEB J., 10, 75-83.
24. Pace, C.N. (1990) Trends Biochem. Sci., 15, 14-17.
25. Kauzmann, W. (1959) Adv. Prot. Chem., 14, 1-63.
26. Privalov, P.L. and Gill, S.J. (1988) Adv. Protein Chem., 39, 191-234.
27. Chothia, C. (1976) J. Mol. Biol., 105, 1-12.
28. Flory, P.J. (1953) Principles of Polymer Chemistry, Cornell University Press, Ithaca, NY.
29. Volkin, D. and Klibanov, A. (1988) in Protein Function: A Practical Approach (Creighton, T.E. Ed.), IRL Press, Oxford, England, pp. 1-24.
30. Khossravi, M.; Shire, S.J. and Borchardt, R.T. (2000) Biochemistry, 39, 5876-5885.
31. Privalov, P.L. (1990) Crit. Rev. Biochem. Mol. Biol., 25, 281-305.
32. Chang, B.S.; Kendrick, B.S. and Carpenter, J.F. (1996) J. Pharm. Sci., 85, 1325-1330.
33. Heremans, K. and Smeller, L. (1998) Biochim. Biophys. Acta, 1386, 353-370.
34. Mozhaev, V.V.; Heremans, K.; Frank, J.; Masson, P. and Balny, C. (1996) Proteins, 24, 81-91.
35. Schmid, G.; Ludemann, H.D. and Jaenicke, R. (1978) Eur. J. Biochem., 86, 219-224.
36. Keenan, R.D.; Young, D.J.; Tier, C.M.; Jones, A.D and Underdown, J. (2001) J. Agric. Food Chem., 49, 3394-3402.
37. Gorovits, B.M. and Horowitz, P.M. (1998) Biochemistry, 37, 6132-6135.
38. St. John, R.J.; Carpenter, J.F. and Randolph, T.W. (1999) Proc. Natl. Acad. Sci. USA, 96, 13029-13033.
39. Lapanje, S. (1978) Physicochemical Aspects of Protein Denaturation, John Wiley and Sons, New York.
40. Shirley, B.A. (1992) in Stability of Protein Pharmaceuticals, Part A: Chemical and Physical Pathways of Protein Degradation (Ahern, T.J. and Manning, M.C. Eds.), Plenum Press, New York, pp. 167-194.
41. Pace, C.N. and Shaw, K.L. (2000) Proteins, Suppl. 4, 1-7.
42. Pace, C.N. (1990) Trends Biotechnol., 8, 93-98.
43. Privalov, P.L. and Makhatadze, G.I. (1992) J. Mol. Biol., 224, 715-723.
44. Remmele, R.L. Jr.; Nightlinger, N.S.; Srinivasan, S. and Gombotz, W.R. (1998) Pharm. Res., 15, 200-208.
45. Gomez, J.; Hilser, V.J.; Xie, D. and Friere, E. (1995) Proteins, 22, 404-412.
46. Montgomery, D.; Jordan, R.; McMacken, R. and Friere, E. (1993) J. Mol. Biol., 232, 680-692.
47. Remmele, R.L. Jr.; Bhat, S.D.; Phan, D.H. and Gombotz, W.R. (1999) Biochemistry, 38, 5241-5247.
48. Kasraian, K.; Kuzniar, A.; Earley, D.; Kamicker, B.J.; Wilson, G.; Manion, T.; Hong, J.; Reiber, C. and Canning, P. (2001) Pharm. Dev. Technol., 6, 441-447.
49. Haynie, D.T. and Freire, E. (1994) Anal. Biochem., 216, 33-41.
50. Manning, M.C. (1993) ACS Symp. Ser., 516, 33-52.
51. Brems, D.N.; Brown, P.L.; Heckenlaible, L.A. and Frank, B.H. (1990) Biochemistry, 29, 9289-9293.
52. Greenfield, N.J. (1996) Anal. Biochem., 235, 1-10.
53. Lakowicz, J.R. (1986) in Principles of Fluorescence Spectroscopy, Plenum Press, New York.
54. Shahrokh, Z.; Eberlein, G. and Wang, Y.J. (1994) J. Pharm. Biomed. Anal., 12, 1035-1041.
55. Pelton, J.T. and McLean, L.R. (2000) Anal. Biochem., 277, 167-176.
56. Carpenter, J.F.; Prestrelski, S.J. and Dong, A. (1998) Eur. J. Pharm. Biopharm., 45, 231-238.
57. Lin, J.J.; Meyer, J.D.; Carpenter, J.F. and Manning, M.C. (2000) Pharm. Res., 17, 391-396.
58. Ma, C.Y.; Rout, M.K. and Mock, W.Y. (2001) J. Agric. Food Chem., 49, 3328-3334,
59. Ghaemmaghami, S.; Fitzgerald, M.C. and Oas, T.G. (2000) Proc. Natl. Acad. Sci. USA, 97, 8296-8301.
60. Kim, Y.S.; Cape, S.P.; Chi, E.; Raffen, R.; Wilkins-Stevens, P.; Stevens, F.J.; Manning, M.C.; Randolph, T.W.; Solomon, A. and Carpenter, J.F. (2001) J. Biol. Chem., 276, 1626-1633.
61. Gekko K. and Timasheff, S.N. (1981) Biochemistry, 20, 4667-4676.
62. Lin, T-Y. and Timasheff, S.N. (1996) Protein Sci., 5, 372-381.
63. Lejeune, A.; Vanhove, M.; Lamotte-Brasseur, J.; Pain, R.H.; Frere, J.; and Matagne, A. (2001) Chem. Biol. 8, 831-842.
64. Cunningham, B.C.; Mulkerrin, M.G. and Wells, J.A. (1991) Science, 253, 545-548.
65. Christova, P.; Cox, J.A. and Craescu, C.T. (2000) Proteins, 40, 177-184.
66. Kerwin, B.A.; Heller, M.C.; Levin, S.H. and Randolph, T.W. (1998) J. Pharm. Sci., 87, 1062-1068.
67. Kreilgaard, L.; Jones, L.S.; Randolph, T.W .; Frokjaer, S.; Flink, J.M.; Manning, M.C. and Carpenter, J.F. (1998) J. Pharm. Sci., 87, 1597-1603.
68. Carpenter, J.F. and Crowe, J.H. (1988) Cryobiology, 25, 244-255.
69. Lai, M.C. and Topp, E.M. (1999) J. Pharm. Sci., 88, 489-500.
70. Cleland, J.L.; Lam, X.; Kendrick, B.; Yang, J.; Yang, T.H.; Overcashier, D.; Brooks, D.; Hsu, C. and Carpenter, J.F. (2001) J. Pharm. Sci., 90, 310-321.
71. Randolph, T.W. (1997) J. Pharm. Sci., 86, 1198-1203.
72. Heller, M.C.; Carpenter, J.F. and Randolph, T.W. (1999) J. Pharm. Sci., 88, 58-64.
73. Kreilgaard, L.; Frokjaer, S.; Flink, J.M.; Randolph, T.W. and Carpenter, J.F. (1999) J. Pharm. Sci., 88, 281-290.
74. Sun, W.Q. and Davidson, P. (1998) Biochim. Biophys. Acta, 1425, 235-244.
75. Hochuli, E. (1997) J. Interferon Cytokine Res., 17, S15-S21.
76. Wierda. D.; Smith, H.W. and Zwickl, C.M. (2001) Toxicology, 158, 71-74.
77. Volkin, D. and Middaugh, C.R. (1992) in Stability of Protein Pharmaceuticals, Part A: Chemical and Physical Pathways of Protein Degradation (Ahern, T.J. and Manning, M.C. Eds.), Plenum Press, New York, pp. 215-247.
78. Glatz, C.E. (1992) in Stability of Protein Pharmaceuticals, Part A: Chemical and Physical Pathways of Protein Degradation (Ahern, T.J. and Manning, M.C. Eds.), Plenum Press, New York, pp. 135-166.
79. Carpenter, J.F.; Kendrick, B.S.; Chang, B.S.; Manning, M.C. and Randolph, T.W. (1999) Methods Enzymol., 309, 236-255.
80. Lumry, R. and Eyring, H. (1954) J. Phys. Chem., 58, 110-125.
81. Minton, K.W.; Karmin, P.; Hahn, G.M. and Minton, A.P. (1982) Proc. Natl. Acad. Sci. USA, 79, 7107-7111.
82. Wetzel, R. (1994) Trends Biotechnol., 12, 193-198.
83. Kendrick, B.S.; Carpenter, J.F.; Cleland, J.L. and Randolph, T.W. (1998) Proc. Natl. Acad. Sci. USA, 95, 14142-14146.
84. Kendrick, B.S.; Chang, B.S.; Arakawa, T.; Peterson, B.; Randolph, T.W.; Manning, M.C. and Carpenter, J.F. (1997) Proc. Natl. Acad Sci. USA, 94, 11917-11922.
85. Kendrick, B.S.; Cleland, J.L.; Lam, X.; Nguyen, T.; Randolph, T.W.; Manning, M.C. and Carpenter, J.F. (1998) J. Pharm. Sci., 87, 1069-1076.
86. Chiti, F.; Mangione, P.; Andreola, A.; Giorgetti, S.; Stefani, M.; Dobson, C.M.; Bellotti, V. and Taddei, N. (2001) J. Mol. Biol., 307, 379-391.
87. Bulone, D.; Martorana, V. and San Biagio, P.L. (2001) Biophys. Chem., 91, 61-69.
88. Burdette D.S.; Tchernajencko, V.V. and Zeikus, J.G. (2000) Enzyme Microb. Technol., 27, 11-18.
89. Lin, Z.; Wang, C.C. and Tsou, C.L. (2000) Biochim. Biophys. Acta, 1481, 283-288.
90. Raffen, R.; Dieckman, L.J.; Szpunar, M.; Wunschl, C.; Pokkuluri, P.R.; Dave, P.; Wilkins Stevens, P.; Cai, X.; Schiffer, M. and Stevens, F.J. (1999) Protein Sci., 8, 509-517.
91. Quintas, A.; Vaz, D.C.; Cardoso, I; Saraiva, M.J. and Brito, R.M. (2001) J. Biol. Chem., 276, 27207-27213.
92. Villegas, V.; Zurdo, J.; Filimonov, V.V.; Aviles, F.X; Dobson, C.M. and Serrano, L. (2000) Protein Sci., 9, 1700-1708.
93. Plaza del Pino, I.M.; Ibarra-Molero, B. and Sanchez-Ruiz, J.M. (2000) Proteins, 40, 58-70.
94. Trojanowski, J.Q. and Lee, V.M. (2000) Ann. N.Y. Acad. Sci., 924, 62-67.
95. Hovorka, S. and Schöneich C. (2001) J. Pharm. Sci., 90, 253-269.
96. Li, S.; Schneich, C. and Borchardt, R.T. (1995) Biotechnol. Bioeng., 48, 490-500.
97. Lam, X.M.; Yang, J.Y. and Cleland, J.L. (1997) J. Pharm. Sci., 86, 1250-1255.
98. Andersson, M.M.; Breccia, J.D. and Hatti-Kaul, R. (2000) Biotechnol. Appl. Biochem., 32, 145-153.
99. Krishnamurthy, R.; Bush, K.D.; Madurawe, R.D. and Lumpkin, J.A. (1995) Biotech. Prog., 11, 643-650.
100. Teh, L.C.; Murphy, L.J.; Huq, N.L.; Surus, A.S.; Friesen, H.G.; Lazarus, L. and Chapman, G.E. (1987) J. Biol, Chem., 262, 6472-6477.
101. Hovorka, S.W.; Hong. J.; Cleland, J.L. and Schoneich, C. (2001) J. Pharm. Sci., 90, 58-69.
102. DePaz, R.A.; Barnett, C.C.; Dale, D.A.; Carpenter, J.F; Gaertner, A.L. and Randolph, T.W. (2000) Arch. Biochem. Biophys., 384, 123-132.
103. Meyer, J.D.; Ho, B. and Manning, M.C. (2002) in Rational Design of Stable Protein Formulations, (Carpenter, J.F. and Manning, M.C. Eds.), Kluwer Press, New York, 85-107.
104. Shacter, E. (2000) Drug Metab. Rev., 32, 307-326.
105. Hlady, V.; Buijs, J. and Jennissen, H.P. (1999) Meth. Enzymol., 309, 402-429.
106. Fang, F. and Szleifer, I. (2001) Biophys. J., 80, 2568-2589,
107. Sato, S.; Ebert, C.D. and Kim, S.W. (1983) J. Pharm. Sci., 72, 228-232.
108. Maruyama, T.; Katoh, S.; Nakajima, M. and Nabetani, H. (2001) Biotechnol. Bioeng., 75, 233-238.
109. Tzannis, S.T.; Hrushesky, W.J.M.; Wood, P.A. and Przybycien, T.M. (1996) Proc. Natl. Acad. Sci. USA, 93, 5460-5465.
110. Carignano, M.A. and Szleifer, I. (2000) Colloids Surf. B: Biointerfaces, 18, 169-182.
111. Zhang, F; Kang, E.T.; Neoh, K.G.; Wang, P. and Tan, K.L. (2001) Biomaterials, 22, 1541-1548.
112. Ruegsegger, M.A. and Marchant, R.E. (2001) J. Biomed. Mater. Res., 56, 159-167.
113. Hasegawa, T.; Iwasaki, Y. and Ishihara, K. (2001) Biomaterials, 22, 243-251.
114. Jones, L.S. and Randolph, T.W. (2001) in Rational Design of Stable Protein Formulations, (Carpenter, J.F. and Manning, M.C. Eds.), Kluwer Press, New York, in press.
115. Bam, N.B.; Randolph, T.W. and Cleland, J.L. (1995) Pharm. Res., 12, 2-11.
116. Arakawa, T. and Kita, Y. (2000) J. Pharm. Sci., 89, 646-651.
117. Chen, B-L.; Arakawa, T.; Hsu, E.; Narhi, L.O.; Tresse, T.J. and Chien, S.L. (1994) J. Pharm. Sci., 83, 1657-1661.
118. Zhang, M.Z.; Pikal, K.; Nguyen, T.; Arakawa, T. and Prestrelski, S.J. (1996) Pharm. Res., 13, 643-646.
119. Gombotz, W.R.; Pankey, S.C.; Bouchard, L.S.; Phan, D.H. and Mackenzie, A.P. (1996) in Formulation, Characterization, and Stability of Protein Drugs: Case Histories (Pearlman, R. and Wang, Y.J., Eds.), Plenum Press, New York, pp. 219-245.
120. Lin, L.S.; Kunitani, M.G. and Hora, M.S. (1996) in Formulation, Characterization, and Stability of Protein Drugs: Case Histories (Pearlman, R. and Wang, Y.J. Eds.), Plenum Press, New York, pp. 275-301.
121. Webb, J.N.; Webb, S.D.; Cleland, J.L.; Carpenter, J.F. and Randolph, T.W. (2001) Proc. Natl. Acad. Sci. USA, 98, 7259-7264.
122. Arakawa, T. and Kita, Y. (2000) Biochim. Biophys. Acta, 1479, 32-36.
123. Gokhale, R.S.; Agarwalla, S.; Santi, D.V.; and Balaram, P. (1996) Biochemistry, 35, 7150-7158.